Herbalife Quarterly Cash Flow Statement
NYSE: HLFHealth CareOther PharmaceuticalsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Herbalife free cash flow
In the quarter ended Jun 30, 2026, Herbalife generated $32.9 million of operating cash flow and spent $11.3 million on capital expenditures. That left free cash flow of $21.6 million, a free-cash-flow margin of 1.6% of revenue. Free cash flow was down 70.5% from the prior year's $73.2 million.
Herbalife returned $9.3 million to shareholders through share repurchases, equal to 43% of free cash flow.
Summary generated from market data by MetaCap's automated system. Methodology
Herbalife cash flow statement (quarterly)
| Quarter (USD) | Q2 20262026-06-30 | Q1 20262026-03-31 | Q4 20252025-12-31 | Q3 20252025-09-30 | Q2 20252025-06-30 | Q1 20252025-03-31 | Q4 20242024-12-31 | Q3 20242024-09-30 | Q2 20242024-06-30 | Q1 20242024-03-31 | Q4 20232023-12-31 | Q3 20232023-09-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | -26.50M | 61.20M | 85.10M | 43.10M | 49.20M | 50.40M | 177.90M | 47.40M | 4.70M | 24.30M | 10.20M | 42.80M |
| Net Income growth (YoY) | -153.86% | +21.43% | -52.16% | -9.07% | +946.81% | +107.41% | +1644.12% | +10.75% | -92.15% | -17.06% | -81.25% | -47.93% |
| Depreciation & Amortization | 31.40M | 29.40M | 29.30M | 30.70M | 30.50M | 30.70M | 29.00M | 30.60M | 32.60M | 29.20M | 28.20M | 28.40M |
| Stock-Based Compensation | 10.10M | 10.60M | 10.90M | 11.20M | 10.40M | 11.60M | 13.30M | 13.00M | 11.80M | 11.90M | 12.30M | 13.70M |
| Change in Working Capital | 10.20M | -28.60M | 23.60M | -28.30M | 21.70M | -27.50M | 52.10M | -26.50M | -900.00K | -20.70M | 9.20M | -1.30M |
| Operating Cash Flow | 32.90M | 113.80M | 98.30M | 138.80M | 96.00M | 200.00K | 69.60M | 99.50M | 102.50M | 13.80M | 96.10M | 79.60M |
| Capital Expenditures | -11.30M | -10.90M | -18.50M | -20.80M | -22.80M | -18.30M | -25.70M | -27.10M | -36.30M | -32.90M | -35.30M | -31.10M |
| Investing Cash Flow | -21.60M | -11.20M | -18.70M | -20.60M | -50.60M | -18.80M | -25.60M | 10.00M | -36.20M | -32.80M | -35.20M | -31.10M |
| Share Repurchases | -9.30M | -700.00K | -100.00K | -1.30M | -4.60M | -2.20M | -2.60M | 0 | -3.40M | -2.30M | -1.30M | -300.00K |
| Debt Issued | 536.50M | 67.00M | 172.50M | 281.50M | 205.80M | 65.00M | 276.70M | 156.00M | 800.50M | 161.20M | 20.20M | 124.00M |
| Debt Repaid | -541.70M | -72.20M | -202.70M | -261.80M | -211.80M | -70.30M | -282.00M | -241.20M | -1.29B | -120.70M | -11.50M | -131.40M |
| Financing Cash Flow | -82.70M | 2.00M | -32.70M | -130.40M | -60.20M | -72.20M | -9.00M | -86.10M | -82.00M | -158.20M | 8.30M | -71.30M |
| Net Change in Cash | -79.60M | 97.70M | 47.30M | -15.60M | -7.40M | -87.10M | 20.20M | 28.60M | -23.20M | -183.00M | 79.50M | -31.30M |
| Free Cash Flow | 21.60M | 102.90M | 79.80M | 118.00M | 73.20M | -18.10M | 43.90M | 72.40M | 66.20M | -19.10M | 60.80M | 48.50M |
This table shows 12 quarterly periods of Herbalife's cash flow statement, from Q2 2026 back to Q3 2023, across 14 line items including net income, depreciation & amortization, stock-based compensation. Values in USD; B = billions, M = millions. Fiscal periods follow HLF's reporting calendar. What is a cash flow statement?